IRD FY 2022 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$349M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$40M+6665.7% YoY

Gross Profit

$40M100.0% margin

Operating Income

$18M45.7% margin

Net Income

$18M44.9% margin

EPS (Diluted)

$0.87

Cash Flow

Operating Cash Flow

$14M

Free Cash Flow

$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$49M

Total Liabilities

$3M

Stockholders' Equity

$46M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$589,000	+6665.7%
Gross Profit	$40M	$589,000	+6665.7%
Operating Income	$18M	-$23M	+180.3%
Net Income	$18M	-$57M	+131.6%